Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

Yang JJ, Cheng C, Yang W, Pei D, Cao X, Fan Y, Pounds SB, Neale G, TreviƱo LR, French D, Campana D, Downing JR, Evans WE, Pui CH, Devidas M, Bowman WP, Camitta BM, Willman CL, Davies SM, Borowitz MJ, Carroll WL, Hunger SP, Relling MV.

JAMA. 2009 Jan 28;301(4):393-403. doi: 10.1001/jama.2009.7.

2.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
3.

Evaluation of tumor cell heterogeneity based on response to chemotherapy.

Asselin BL.

Clin Chim Acta. 1992 Mar 13;206(1-2):33-44. Review.

PMID:
1572078
4.

Biology of childhood acute lymphoblastic leukemia.

Bhojwani D, Yang JJ, Pui CH.

Pediatr Clin North Am. 2015 Feb;62(1):47-60. doi: 10.1016/j.pcl.2014.09.004. Review.

5.

Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.

Urayama KY, Chokkalingam AP, Manabe A, Mizutani S.

Int J Hematol. 2013 Jan;97(1):3-19. doi: 10.1007/s12185-012-1220-9. Epub 2012 Dec 13. Review.

PMID:
23239135
6.

Pharmacogenomics in acute lymphoblastic leukemia.

Lee SHR, Yang JJ.

Best Pract Res Clin Haematol. 2017 Sep;30(3):229-236. doi: 10.1016/j.beha.2017.07.007. Epub 2017 Jul 27. Review.

PMID:
29050696

Supplemental Content

Support Center